# Infliximab-Induced Improvement in Dercum's Disease

**Authors:** Cailean E McKay, Ishaan Batish, Shiva Arami

PMC · DOI: 10.7759/cureus.61499 · Cureus · 2024-06-01

## TL;DR

A patient with Dercum's disease showed improvement after treatment with infliximab and methotrexate.

## Contribution

This case report presents a potential new treatment approach for Dercum's disease using infliximab.

## Key findings

- A patient with Dercum's disease showed improvement with infliximab and methotrexate.
- Current treatment for Dercum's disease is limited to pain management.

## Abstract

Dercum’s disease (DD) is a rare and poorly understood disease characterized by obesity and painful lipomas throughout the body. Although the entity is well described in the literature, its etiology, prevalence, and treatment remain unclear. Currently, treatment is focused on pain management. We describe a case of a patient with DD who showed improvement with infliximab and methotrexate.

## Linked entities

- **Chemicals:** methotrexate (PubChem CID 4112)
- **Diseases:** Dercum's disease (MONDO:0007070), obesity (MONDO:0011122)

## Full-text entities

- **Diseases:** pain (MESH:D010146), DD (MESH:D000274), obesity (MESH:D009765)
- **Chemicals:** methotrexate (MESH:D008727), Infliximab (MESH:D000069285)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11216115/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11216115/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC11216115/full.md

---
Source: https://tomesphere.com/paper/PMC11216115